Versant Capital Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
Versant Capital Management's MEDP Position: Q3 2026 in Review
Versant Capital Management increased its Medpace (MEDP) stake by 0.33% in Q3 2026, buying an estimated $586 and bringing the position to 304 shares worth $190K. The position accounts for 0.02% of the portfolio, ranked #635.
Versant Capital Management first reported a position in MEDP in Q3 2019 and has held it in 15 quarters since. 759 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.
- Versant Capital Management held 304 shares of Medpace worth $190K as of Q3 2026.
- Versant Capital Management bought 1 Medpace share in Q3 2026, an estimated $586.
- Medpace made up 0.02% of Versant Capital Management's portfolio in Q3 2026, its #635 holding.
- Versant Capital Management first reported a position in Medpace in Q3 2019 and has held it in 15 quarters since.
- 759 funds tracked by Wall St. Rank held Medpace as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.